June 28, 2023 A study of more than 22,000 people with multiple sclerosis (MS) has for the first time identified a genetic variant associated with faster progression of the disease, an accumulation of disability ...
June 28, 2023 Scientists identify the first genetic marker for MS severity, opening the door to preventing long-term ...
June 15, 2023 A new study has identified a treatment that could repair myelin in the cortex, undoing some of the damage caused by ...
June 12, 2023 A decade after scientists identified an over-the-counter antihistamine as a treatment for multiple sclerosis, researchers have developed an approach to measure the drug's effectiveness in ...
Mar. 16, 2023 Criteria used by neurologists to assess for multiple sclerosis (MS) in adults may fail to identify the illness in children with imaging suspicious for the disease, an oversight that could delay ...
Mar. 8, 2023 A pilot trial tested the nasal administration of the drug Foralumab, an anti-CD3 monoclonal antibody. Investigators found evidence that the drug dampened the inflammatory T cell response and ...
Mar. 6, 2023 Scientists have uncovered a chemical compound that holds potential as a therapeutic for various autoimmune diseases, and they've used it to treat ...
Feb. 1, 2023 A researcher is one step closer to demonstrating the potential of a brain molecule called fractalkine to halt and even reverse the effects of multiple sclerosis and other neurodegenerative diseases. ...
Dec. 21, 2022 In people with active secondary progressive multiple sclerosis (MS), hematopoietic stem cell transplants may delay disability longer than some other MS medications, according to a new study. The ...
Dec. 12, 2022 Multiple Sclerosis (MS) is almost always accompanied by fatigue, a massive tiredness that is described by the vast majority of patients as the most distressing symptom. In a recent scientific study, ...
Nov. 18, 2022 A study has found that anti-hyperglycemic medications used to treat Type 2 diabetes resulted in an increased risk of multiple sclerosis for people older than 45, particularly among ...
Nov. 10, 2022 Blood stem cell transplantation is a radical but highly effective therapy for multiple sclerosis. A study has now examined in detail the way in which the treatment curbs the autoimmune disease and ...
Nov. 4, 2022 Sex differences in the aging brain may offer an enticing clue for developing more effective neuroprotective treatments, according to a new research ...
Oct. 6, 2022 The drug tofacitinib was well tolerated among patients with early scleroderma, primarily affecting the protein interferon both in fibroblasts and keratinocytes. Researchers say the drug is safe and ...
Oct. 6, 2022 Researchers demonstrate the relationship between the rate of cognitive fatigue in MS and microstructural brain changes. The findings promise to advance development of clinical interventions for ...
Sep. 20, 2022 The zebrafish serves as a model organism for researchers around the world: it can be used to study important physiological processes that also take place in a similar form in the human body. It is ...
Sep. 1, 2022 A new study suggests a simple blood test -- administered before CAR-T cell treatment is initiated -- may identify which patients are predisposed to developing neurotoxic side effects in the days and ...
Aug. 24, 2022 Researchers have known people who live farther from the equator are more likely to develop multiple sclerosis (MS) and have often attributed that to vitamin D exposure. But countries farther from the ...
Aug. 10, 2022 Quality of life is a measure of a person's level of comfort, health and happiness. For people with multiple sclerosis (MS), a new study has found there are specific factors that may affect a ...
Aug. 10, 2022 Drugs called interferon betas are common treatments for multiple sclerosis (MS), reducing relapses and slowing motor function decline. Interferon beta, a protein known to contain a zinc binding ...